8:47 AM
 | 
Jan 02, 2018
 |  BC Extra  |  Financial News

CMAB raises $38M series A

CMAB Biopharma Inc. (Suzhou, China) raised $38 million in a series A round led by C-Bridge Capital and BioBay. I-Bridge...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >